Effectiveness of tibolone on hypoestrogenic symptoms induced by goserelin treatment in patients with endometriosis

Fertility and Sterility

Volumn 67, Issue 1, 1997, Pages 40-45

  Taskin, Omur ^a,b   Yalcinoglu, A Ihsan ^a   Kucuk, Senol ^a   Uryan, Ismail ^a   Buhur, Ali ^a   Burak, Feza ^a  

^a INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b INONU UNIVERSITY   (Turkey)

Author keywords

add back therapy; endometriosis; GnRH a; hypoestrogenism; tibolone

Indexed keywords

GONADORELIN AGONIST; GOSERELIN; PLACEBO; TIBOLONE;

ADULT; ARTICLE; BONE METABOLISM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENDOMETRIOSIS; ESTROGEN DEFICIENCY; FEMALE; HOT FLUSH; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0031019505     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(97)81853-5     Document Type: Article

References (12)

1. Meldrum DL, Chang RJ, Vale W, Rivier J, Judd HL. "Medical oophorectomy" using a long acting GnRH agonist: a possible new approach to the treatment of endometriosis. J Clin Endocrinol Metab 1982;54:1081-3.
2. Haney AF. The pathogenesis and etiology of endometriosis. In: Thomas E, Rock J, editors. Modern approaches to endometriosis. Dordrecht, The Netherlands: Kluver Academic Publishers, 1991:3-19.
3. Erickson LD, Ory SJ. GnRH analogues in the treatment of endometriosis. Obstet Gynecol Clin North Am 1989;16:23-45.
4. Kennedy SH, Williams IA, Brodribb J, Barlow DH, Shaw RW. A comparison of nafarelin acetate and danazol in the treatment of endometriosis. Fertil Steril 1990;53:998-1003.
5. Stevenson JC, Lees B, Gardner R, Shaw RW. A comparison of the skeletal effects of goserelin and danazol in premenopausal women with endometriosis. Horm Res 1989;32 Suppl:161-4.
6. Barbieri RL. Hormone treatment of endometriosis: the estrogen threshold hypothesis. Am J Obstet Gynecol 1992;166:740-5.
7. The American Fertility Society. Revised American Fertility Society classification of endometriosis: 1985. Fertil Steril 1985;43:351-2.
8. Tax L, Goorissen EM, Kicovic PM. Clinical profile of Org tibolone. Maturitas 1987;9:Suppl 1:3-13.
9. Benedek-Jaszmann LJ. Long-term placebo-controlled efficacy and safety study of Org tibolone in climacteric women. Maturitas 1987;9:Suppl 1:25-33.
10. Volpe A, Facchinetti F, Grasso A, Petraglia F, Campanini D, Genazzani A. Benefits and risks of different hormonal replacement therapies in post-menopausal women. Maturitas 1986;8:327-34.
11. Judd HL. Gonadotropin-releasing hormone agonists: strategies for managing the hypoestrogenic effects of therapy. Am J Obstet Gynecol 1992;166:725-6.
12. Barbieri RL. Gonadotropin-releasing hormone agonist and estrogen-progestogen replacement therapy. Am J Obstet Gynecol 1990;162:593-5.